Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer
Cited by 11
Related Papers
AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program
|The Journal of Experimental Medicine|2017|171